Your browser doesn't support javascript.
loading
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease.
Carlsen, Arne; Omdal, Roald; Leitao, Kristian Øgreid; Isaksen, Kjetil; Hetta, Anne Kristine; Karlsen, Lars Normann; Aabakken, Lars; Bolstad, Nils; Warren, David; Lundin, Knut E A; Grimstad, Tore.
Afiliación
  • Carlsen A; Stavanger University Hospital, PO Box 8100, 4068 Stavanger, Norway.
  • Omdal R; Unit of Clinical Immunology, Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Leitao KØ; Unit of Gastroenterology, Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Isaksen K; Unit of Gastroenterology, Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Hetta AK; Unit of Gastroenterology, Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Karlsen LN; Unit of Gastroenterology, Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Aabakken L; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
  • Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Warren D; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Lundin KEA; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
  • Grimstad T; Unit of Gastroenterology, Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
Therap Adv Gastroenterol ; 11: 1756284818759930, 2018.
Article en En | MEDLINE | ID: mdl-29623105
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2018 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2018 Tipo del documento: Article País de afiliación: Noruega